200 related articles for article (PubMed ID: 17136660)
1. [Immunointervention in newly diagnosed type 1 diabetes].
Kaupper T; Walter M; Ziegler AG
Dtsch Med Wochenschr; 2006 Dec; 131(49):2783-8. PubMed ID: 17136660
[No Abstract] [Full Text] [Related]
2. Immunointervention in type 1 (insulin-dependent) diabetes mellitus.
Keymeulen B; Somers G
Acta Clin Belg; 1993; 48(2):86-95. PubMed ID: 8392249
[TBL] [Abstract][Full Text] [Related]
3. Immunointervention in insulin dependent diabetes: implications for the epidemiology of the disease.
Visalli N; Pozzilli P; Boccuni ML; Suppa MA; Messina R; Buzzetti R; Andreani D
Ann Ig; 1992; 4(3):159-63. PubMed ID: 1284515
[No Abstract] [Full Text] [Related]
4. [Antibodies instead of insulin?].
Anders S; Kühnemund L; Stauch M; Zündorf I; Dingermann T
Pharm Unserer Zeit; 2010 Mar; 39(2):97-8. PubMed ID: 20196056
[No Abstract] [Full Text] [Related]
5. [Immunosuppression in Type I diabetes mellitus].
Schönle EJ; Sizonenko PC; Spinas GA
Schweiz Rundsch Med Prax; 1990 Oct; 79(41):1225-7. PubMed ID: 2237051
[TBL] [Abstract][Full Text] [Related]
6. [Immune modulation therapy in type I diabetes mellitus].
Schmeidl R; Teuber J; Paschke R; Schwedes U; Usadel KH
Fortschr Med; 1986 Dec; 104(45):879-83. PubMed ID: 3542769
[No Abstract] [Full Text] [Related]
7. [Immunology of insulin-dependent diabetes. Towards practical applications].
Boitard C; Timsit J; Bach J
Ann Endocrinol (Paris); 1992; 53(3):98-101. PubMed ID: 1295439
[No Abstract] [Full Text] [Related]
8. [Immunotherapy of type 1 diabetes].
Timsit J; Boitard C; Bach JF
Rev Prat; 1992 May; 42(9):1075-9. PubMed ID: 1496232
[TBL] [Abstract][Full Text] [Related]
9. Clinical studies. Trying to reset the clock on type 1 diabetes.
Couzin-Frankel J
Science; 2011 Aug; 333(6044):819-21. PubMed ID: 21835995
[No Abstract] [Full Text] [Related]
10. [(Auto)immunological aspects of type 1 diabetes mellitus].
Dieterle C
MMW Fortschr Med; 2006 Apr; 148(16):36-9; quiz 40. PubMed ID: 16688947
[TBL] [Abstract][Full Text] [Related]
11. Immune intervention with anti-CD3 in diabetes.
Harlan DM; von Herrath M
Nat Med; 2005 Jul; 11(7):716-8. PubMed ID: 16015359
[No Abstract] [Full Text] [Related]
12. [Environmental factors in the development of type 1 diabetes -- a new insight].
Płaczkiewicz-Jankowska E; Szybiński Z; Huszno B
Przegl Lek; 2007; 64(3):175-9. PubMed ID: 17941471
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of pre-insulin dependent diabetes.
Gottlieb PA; Eisenbarth GS
Annu Rev Med; 1998; 49():391-405. PubMed ID: 9509271
[TBL] [Abstract][Full Text] [Related]
14. Tackling type 1 diabetes: new immune-modulating drugs attack the root cause.
Shekhar C
Chem Biol; 2007 Dec; 14(12):1305-6. PubMed ID: 18096495
[No Abstract] [Full Text] [Related]
15. New developments in non-specific and semi-specific immunosuppression in type I diabetes.
Leslie RD; Carotenuto P; Pozzilli P
Diabetes Metab Rev; 1993 Dec; 9(4):257-67. PubMed ID: 7924823
[No Abstract] [Full Text] [Related]
16. Immunotherapy of insulin-dependent diabetes.
Bell DS; Acton RT
Ala J Med Sci; 1985 Jul; 22(3):311-4. PubMed ID: 4025722
[No Abstract] [Full Text] [Related]
17. Autoantibodies in diabetes mellitus: current utility and perspectives.
Isermann B; Ritzel R; Zorn M; Schilling T; Nawroth PP
Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):483-90. PubMed ID: 17853330
[TBL] [Abstract][Full Text] [Related]
18. Outlook for immune intervention in type I diabetes.
Grob PJ
Curr Probl Clin Biochem; 1983; 12():119-40. PubMed ID: 6360542
[No Abstract] [Full Text] [Related]
19. Trials of immunotherapy to preserve beta-cell function of prediabetic and new-onset patient trials.
Eisenbarth GS
Curr Diab Rep; 2004 Apr; 4(2):85-6. PubMed ID: 15035966
[No Abstract] [Full Text] [Related]
20. Vitamin D in diabetes mellitus-a new field of knowledge poised for D-velopment.
Alfonso B; Liao E; Busta A; Poretsky L
Diabetes Metab Res Rev; 2009 Jul; 25(5):417-9. PubMed ID: 19565622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
